Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1319-1332
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1319
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1319
Figure 1 Interaction between Bacterial Lipopolysaccharides and Toll-like receptor 4 signaling pathway in hepatocellular carcinoma development.
LPS: Lipopolysaccharides; MyD88: Myeloid differentiation primary response protein 88; IRAK1/4: IL-1 receptor associated kinase 1/4; TRAF6: TNF receptor associated factor 6; TAK1: TGF-activated kinase 1; TAB2/3: TAK1-binding protein 2/3; NEMO: NF-kappa-B essential modulator; IKB: Inhibitor of nuclear factor kappa-B; NF-κB: Nuclear factor kappa B.
- Citation: Spanu D, Pretta A, Lai E, Persano M, Donisi C, Mariani S, Dubois M, Migliari M, Saba G, Ziranu P, Pusceddu V, Puzzoni M, Astara G, Scartozzi M. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World J Hepatol 2022; 14(7): 1319-1332
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1319.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1319